Trial intelligence / Profile preview

Effect of Sedation With Dexmedetomidine-esketamine Combination on Delirium in Postoperative ICU Patients

NCT07151716Phase 4Completed

Sponsor
Peking University First Hospital
Start
Oct 2025
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of esketamine in delirium, sponsored by Peking University First Hospital. Started Oct 2025; status: completed.

02

Drugs

esketamine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT07151716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07151716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call